Technique
Supplier
Species
Label
Iso Type
Host
Tissue
anti-CDKN1B / KIP1 control peptide Antibody
anti-CDKN1B / KIP1 control peptide Antibody size: 0,25 mg 442
Supplier
ACR
Price
442
Size
0,25 mg
Contact us
Ask Component cell markers and DNA bp. markers are genetic markerser genes
or DNA sequenceswith
selection audit
| Vial description | p27Kip1 |
| Category | control peptide |
| Raised in | laboratory |
| Clone | 1 vial |
| Form | pure |
| Reactivity | not determined |
| Purity | purified |
| Molecular weight | in kDa |
| Source | mammalian |
| Activity | to be determined |
| Range | broad |
| Protein number | P46527 |
| Application | not determined |
| Storage | Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description | , Freeze thaw will destroy a percentage in every cycle and should be avoided, Isotype or positive controls by peptides, Peptides short amino acid chains or epitopes or blocking antagonists, The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs, The shortest peptides are dipeptides, These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), and unbranched synthetic peptide chains, antibodies and deactivated samples, consisting of 2 amino acids joined by a single peptide bond, continuous, followed by tripeptides, or in continue produced for custom peptide synthesis projects, tetra peptides, till polypeptides that are long, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Gene target | CDKN1B / KIP1 peptide |
| Short name | anti-CDKN1B / KIP1 control peptide Antibody |
| Technique | antibodies against human proteins, antibodies for, antibody to, peptides, Antibody |
| Alternative name | Kip1) / KIP1 reference short protein sequence (Antibody to), antibody to-cyclin-dependent kinase inhibitor 1B (p27 |
| Alternative technique | antibodies |
| Alternative to gene target | CDKN1B and IDBG-20317 and ENSG00000111276 and 1027, CDKN1B and IDBG-639416 and ENSBTAG00000018254 and 512613, CDKN4 and KIP1 and MEN1B and MEN4 and P27KIP1, Cdkn1b and IDBG-194318 and ENSMUSG00000003031 and 12576, DNA-templated and biological process this GO :0045930 and negative regulation of mitotic cell cycle and biological process this GO :0046686 and response to cadmium ion and biological process this GO :0048011 and neurotrophin TRK receptor signaling pathway and biological process this GO :0048015 and phosphatidylinositol-mediated signaling and biological process this GO :0048102 and autophagic cell death and biological process this GO :0048839 and inner ear development and biological process this GO :0050680 and negative regulation of epithelial cell proliferation and biological process this GO :0051087 and chaperone binding and molecular function this GO :0051271 and negative regulation of cellular component movement and biological process this GO :0060770 and negative regulation of epithelial cell proliferation involved in prostate gland development and biological process this GO :0071236 and cellular response to antibiotic and biological process this GO :0071285 and cellular response to lithium ion and biological process this GO :0071407 and cellular response to organic cyclic compound and biological process this GO :0071850 and mitotic cell cycle arrest and biological process this GO :0071901 and negative regulation of protein serine/threonine kinase activity and biological process, Kip1), cytoplasmic mediator activity, cytoplasmic mediator activity and also this GO :0005515: protein binding and also this GO :0008656: cysteine-type endopeptidase activator activity involved in apoptotic process and also this GO :0019903: protein phosphatase binding and also this GO :0030544: Hsp70 protein binding and also this GO :0032403: protein complex binding and also this GO :0051087: chaperone binding, cytoplasmic mediator activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005654 and nucleoplasm and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005768 and endosome and cellular component this GO :0005829 and cytosol and cellular component this GO :0006813 and potassium ion transport and biological process this GO :0006919 and activation of cysteine-type endopeptidase activity involved in apoptotic process and biological process this GO :0006977 and DNA damage response, nuclei, signal transduction by p53 class mediator resulting in cell cycle arrest and biological process this GO :0007050 and cell cycle arrest and biological process this GO :0007173 and epidermal growth factor receptor signaling pathway and biological process this GO :0007605 and sensory perception of sound and biological process this GO :0008219 and cell death and biological process this GO :0008284 and positive regulation of cell proliferation and biological process this GO :0008285 and negative regulation of cell proliferation and biological process this GO :0008543 and fibroblast growth factor receptor signaling pathway and biological process this GO :0008656 and cysteine-type endopeptidase activator activity involved in apoptotic process and molecular function this GO :0009749 and response to glucose and biological process this GO :0010942 and positive regulation of cell death and biological process this GO :0014070 and response to organic cyclic compound and biological process this GO :0019903 and protein phosphatase binding and molecular function this GO :0030308 and negative regulation of cell growth and biological process this GO :0030544 and Hsp70 protein binding and molecular function this GO :0031116 and positive regulation of microtubule polymerization and biological process this GO :0032355 and response to estradiol and biological process this GO :0032403 and protein complex binding and molecular function this GO :0033673 and negative regulation of kinase activity and biological process this GO :0038095 and Fc-epsilon receptor signaling pathway and biological process this GO :0042326 and negative regulation of phosphorylation and biological process this GO :0042493 and response to drug and biological process this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0043200 and response to amino acid and biological process this GO :0043234 and protein complex and cellular component this GO :0043434 and response to peptide hormone and biological process this GO :0045087 and innate immune response and biological process this GO :0045732 and positive regulation of protein catabolic process and biological process this GO :0045736 and negative regulation of cyclin-dependent protein serine/threonine kinase activity and biological process this GO :0045892 and negative regulation of transcription, this GO :0000079 and regulation of cyclin-dependent protein serine/threonine kinase activity and biological process this GO :0000082 and G1/S transition of mitotic cell cycle and biological process this GO :0000278 and mitotic cell cycle and biological process this GO :0001666 and response to hypoxia and biological process this GO :0004861 and cyclin-dependent protein serine/threonine kinase inhibitor activity and molecular function this GO :0005072 and transforming growth factor beta receptor, this GO :0004861: cyclin-dependent protein serine/threonine kinase inhibitor activity, this GO :0004861: cyclin-dependent protein serine/threonine kinase inhibitor activity and also this GO :0005072: transforming growth factor beta receptor, this GO :0005072: transforming growth factor beta receptor, this GO :0005515: protein binding, this GO :0008656: cysteine-type endopeptidase activator activity involved in apoptotic process, this GO :0019903: protein phosphatase binding, this GO :0030544: Hsp70 protein binding, this GO :0032403: protein complex binding, this GO :0051087: chaperone binding, transforming growth factor beta receptor, cyclin-dependent kinase inhibitor 1B (p27 |
| Identity | 1785 |
| Gene | CDKN1B |
| Long gene name | cyclin dependent kinase inhibitor 1B |
| Synonyms gene name | Kip1) , cyclin-dependent kinase inhibitor 1B (p27 |
| Synonyms | KIP1 P27KIP1 |
| Locus | 12p13, 1 |
| Discovery year | 1995-09-14 |
| GenBank acession | AF480891 |
| Entrez gene record | 1027 |
| Pubmed identfication | 8033212 |
| RefSeq identity | NM_004064 |
| Havana BLAST/BLAT | OTTHUMG00000149914 |